What is the price target for ALVAL stock?
11 analysts have analysed ALVAL.PA and the average price target is 2.24 EUR. This implies a price increase of 119.57% is expected in the next year compared to the current price of 1.022.
VALBIOTIS SA (ALVAL.PA) Forecast, Price Target & Analyst Ratings
EPA:ALVAL • FR0013254851
Current stock price
1.022 EUR
-0.06 (-5.89%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VALBIOTIS SA (ALVAL.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€2.24
Upside
+ 119.57%
From current price of €1.02 to mean target of €2.24, Based on 11 analyst forecasts
Low
€2.12
Median
€2.24
High
€2.42
Price Target Revisions
1 Month
3.13%
3 Months
1.54%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for ALVAL.PA. The average price target is 2.24 EUR. This implies a price increase of 119.57% is expected in the next year compared to the current price of 1.022.
The average price target has been revised upward by 1.54% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.45%
ALVAL.PA was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ALVAL.PA.
In the previous month the buy percentage consensus was at a similar level.
ALVAL.PA was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | MIDCAP PARTNERS | Maintains | Buy -> Buy |
| 2026-01-26 | PORTZAMPARC BNP PARIBAS | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.733M 502.93% | 175K -96.30% | 905K 417.14% | 4.996M 452.04% | 15.862M 217.49% | 32.651M 105.84% | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | -6.444M 42.33% | -9.836M -52.64% | -9.198M 6.49% | -7.21M 21.61% | -875.5K 87.86% | 5.562M 735.29% | 12.394M 122.83% | 13.134M 5.97% | 16.094M 22.54% | 18.683M 16.09% | |
| EBIT YoY % growth | -7.18M 40.30% | -10.423M -45.17% | -9.494M 8.91% | -6.077M 35.99% | -618K 89.83% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -151.70% | -5,956.00% | -1,049.06% | -121.64% | -3.90% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 38.29% | N/A -2.92% | N/A 34.34% | -0.35 25.36% | -0.07 81.07% | 0.10 253.85% | N/A | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
30.40%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
227.80%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
37.33%
EBIT Next 5 Year
27.68%
VALBIOTIS SA / ALVAL.PA Forecast FAQ
How many analysts cover VALBIOTIS SA (ALVAL.PA) stock?
The number of analysts covering VALBIOTIS SA (ALVAL.PA) is 11.